Anti-Infective Agents Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

The Global Anti-Infective Agents Market Size accounted for USD 122.1 Billion in 2021 and is estimated to achieve a market size of USD 161.6 Billion by 2030 growing at a CAGR of 3.6% from 2022 to 2030. Extensive research and development activities in the creation of novel medications with excellent potential and efficiency against multi-drug microbial resistance are one of the primary causes driving the anti-infective agents market growth. Furthermore, new antibacterial and antifungal drug developments are expected to boost the anti-infective agents market value over the projection period.

Anti-Infective Agents Market Report Key Highlights

• Global anti-infective agents market revenue is expected to increase by USD 161.6 Billion by 2030, with a 3.6% CAGR from 2022 to 2030
• North America region led with more than 28% of anti-infective agents market share in 2021
• Asia-Pacific anti-infective agents market growth will observe strongest CAGR from 2022 to 2030
• By type, the antiviral segment has accounted market share of over 48% in 2021
• By distribution channel, hospital pharmacies segment engaged more than 32% of the total market share in 2021
• Increasing prevalence of contagious diseases, fuels the anti-infective agents market size

An anti-infective agent is a medication that can prevent or stop the growth of an infectious organism. Anti-infective agents also can completely destroy the infectious organism. Antifungals, anthelmintics, antimalarials, anthelmintics, antituberculosis drugs, antivirals, as well as antiprotozoals comprise the anti-infective class.

Global Anti-Infective Agents Market Trends

Market Drivers

• Increasing global geriatric population
• Growing incidence of target diseases including respiratory viruses, STIs, and hospital-acquired infections
• Rising efforts to raise awareness of contagious diseases

Market Restraints

• Advancement of multidrug-resistant organisms
• High R&D costs

Market Opportunities

• Rising investments in anti-infective drug research and development
• Increasing the number of drugs approved for the treatment

Anti-Infective Agents Market Report Coverage

The rising predominance of irresistible illnesses, for example, HIV, H1N1, and Ebola infection mirror the significant changes in the standards of conduct of networks over the ongoing decades. The societal changes and expanding mindfulness among medicinal services experts and patients are driving the growth. Broad R&D endeavors relating to the advancement of new medications with high viability and intensity against multi-sedate safe miniaturized scale living beings are one of the main considerations invigorating the growth.

For example, in 2016, the Food and Drug Administration (FDA) affirmed drugs, for example, Discovery by Gilead, for the treatment of HIV-1 contamination and Zephier by Merck that objectives constant Hepatitis C infection (HCV) genotypes 1 or 4 diseases in grown-ups.

Associations, for example, the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) are effectively engaged in spreading mindfulness among individuals in regard to the lethal ramifications of irresistible illnesses and the significance of early treatment. The CDC has teamed up with the National Health Ministry (NHM) to try to spread mindfulness and to upgrade the treatment of transferable illnesses in creating nations, for example, Brazil, China, Nigeria, and India.

Nevertheless, the presentation of novel therapeutics with expanded strength and viability and the commercialization of pipeline items, for example, the commercialization of Omadacycline in 2018 for the treatment of Community-Acquired Bacterial Pneumonia (CABP), are required to drive the growth of the anti-infective agents market. Most organizations are growing their item portfolios by concentrating on undiscovered chances. For example, Gilead propelled Sovaldi, the main ever oral prescription for the treatment of HCV genotype 2 and 3 in 2013.

Anti-Infective Agents Market Segmentation            

The global anti-infective agents market segmentation is based on type, route of administration, distribution channel, and geography.

Anti-Infective Agents Market By Type

• Antibacterials
  • Cephalosporins
  • Fluoroquinolones
  • Penicillin
  • Carbapenem
  • Macrolides
  • Others
• Antivirals
  • Echinocandins
  • Azoles
  • Polyenes
  • Others
• Antifungals 

According to an anti-infective agents industry analysis, antivirals are expected to account for the majority of the market in 2021, owing to the high cost of new intensive anti-viral treatments such as Vicriviroc for the treatment of HIV. The antibacterial portion is anticipated to enroll the quickest CAGR during the conjecture time frame, as antibacterial is the principal line of treatment for a vast scope of diseases. Expanded medicine and the availability of antibacterial due to their over-the-counter status are anticipated to additionally drive the fragment.

The advancement of blended medications to treat and forestall genuine and hazardous diseases is relied upon to push the utilization of anti-infective medications. For example, in 2012, Gilead Sciences, Inc. propelled Stribild, a far-reaching treatment routine comprehensive of four medications (cobicistat, elvitegravir, emtricitabine, and tenofovirdisoproxilfumarate) utilized for the treatment of HIV patients without earlier retroviral treatment record.

Anti-Infective Agents Market By Route of Administration

• Topical
• IV
• Oral
• Others

In terms of the route of administration, the oral course of the organization was assessed to be the biggest portion in 2021 attributable to new item improvement and the nearness of a solid item pipeline. Medical clinic drug stores drove the anti-infective agents market in 2021 while the web-based business is relied upon to be the quickest developing fragment during the figure time frame. Viable illness the executives includes a scope of long haul methodologies, for example, new item advancement, mergers and acquisitions, co-improvement, and business extensions. For example, in 2015, ReViral got financing of USD 21 million for the improvement of its RV521 sedate from the Wellcome Trust.

Anti-Infective Agents Market By Distribution Channel

• Hospital Pharmacies
• E-Commerce
• Specialty Pharmacies
• Retail Pharmacies
• Others

According to the anti-infective agents market forecast, the E-commerce category was predicted to develop at an exponential rate over the projected period. When relative to other distribution channels, this growth is due to convenience, adaptability, and simplicity. Various reasons, such as ease of purchase and improved healthcare facilities in developing nations, are projected to boost expansion.

Anti-Infective Agents Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)